Retraining and Control Therapy (ReACT) R33 Phase
NCT06007053 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2026-03-17
Summary
The purpose of this study is to assess sense of control and catastrophic symptom expectations as targets for Retraining and Control Therapy (ReACT- an intervention focused on changing behaviors and thoughts) for treatment of pediatric psychogenic non-epileptic seizures (PNES, episodes resembling epileptic seizures but with no correlated epileptiform activity). 11-18-year-olds diagnosed with PNES will engage in twelve sessions of either ReACT or supportive therapy. Sense of control over actions will be measured by the magic and turbulence task, a well-validated measure of sense of control. Participants will complete the cold pressor test (CPT) in which participants hold their hand in cool water for as long as possible up to 3 minutes. Catastrophic symptom expectations in response to the CPT will be measured by Pain Catastrophizing Scale for Children (PCS-C), pain tolerance (time with hand in water) and cortisol response. Target assessments occur 7 days before treatment, 7 days after 12th treatment session, and 2 months after the 12th treatment session. Long term follow-up assessments will occur 6 months and 12 months after the 12th treatment session. PNES frequency will be measured from 30 days before to 12 months after treatment.
Conditions
- Convulsion, Non-Epileptic
Interventions
- BEHAVIORAL
-
ReACT
ReACT is a novel cognitive behavioral treatment and is a PNES intervention that targets sense of control and catastrophic symptom expectations. ReACT consists of 12 sessions of therapy focused on teaching adolescents to regain control of their body through managing thoughts and behaviors that reinforce the PNES and return to previous activities. It teaches parents how to respond to PNES in a manner that encourages the adolescents to regain control of their body. The PNES is explained as behaviors learned through classical and operant conditioning.
- BEHAVIORAL
-
Supportive Therapy
The supportive therapy treatment consists of 12 sessions of therapy focused on discussing daily difficulties and/or stressors they experience and identifying stress triggers for PNES. The PNES is explained as physical manifestations of psychological stress.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Aaron Fobian, PhD · University of Alabama at Birmingham
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-03-09
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study in Pediatric Participants With Generalized Anxiety Disorder
NCT01226511 ·Status: COMPLETED ·Phase: PHASE3
-
Managing Anxiety in Pediatric Primary Care (MAPP)
NCT06104904 ·Status: RECRUITING ·Phase: NA
-
A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD
NCT03841773 ·Status: TERMINATED ·Phase: PHASE3
-
Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders
NCT03585010 ·Status: COMPLETED ·Phase: NA
-
Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder
NCT00203385 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Obsessive Compulsive Disorder in Children
NCT00074815 ·Status: COMPLETED ·Phase: PHASE3
-
Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
NCT00515255 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder Symptoms
NCT06202677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)
NCT00703833 ·Status: COMPLETED ·Phase: PHASE2
-
Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders
NCT03182075 ·Status: COMPLETED ·Phase: NA
-
Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)
NCT00000386 ·Status: COMPLETED ·Phase: PHASE3
-
Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
NCT04174365 ·Status: COMPLETED ·Phase: PHASE3
-
Microtuning a Bonafide Treatment for GAD Patients - A Randomized Controlled Trial.
NCT02039193 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
NCT01933919 ·Status: COMPLETED ·Phase: PHASE3
-
Selective Prevention of Anxiety Disorders in Children: A Parent Training Intervention for Anxious Parents
NCT02386410 ·Status: COMPLETED ·Phase: NA
-
Fluoxetine for Anxious Children
NCT00000381 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety
NCT02153944 ·Status: COMPLETED ·Phase: PHASE4
-
The Relative Effects of Three Parent-Intervention Components to Reduce Children's Anxiety
NCT05854602 ·Status: COMPLETED ·Phase: NA
-
Mobile App for Obsessive-compulsive Disorder in Adolescents
NCT06033391 ·Status: COMPLETED ·Phase: NA
-
Long-Term Lithium Treatment for Aggressive Conduct Disorder
NCT00000385 ·Status: COMPLETED ·Phase: PHASE3
-
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
NCT06526260 ·Status: RECRUITING ·Phase: NA
-
iExposure Intervention for Social Anxiety
NCT06409247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders
NCT03033056 ·Status: COMPLETED
-
Manualised Cognitive Behavioral Therapy of Anxiety Disorders in Children and Adolescents in Routine Care Setting
NCT02077205 ·Status: UNKNOWN ·Phase: NA
-
Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial
NCT01296321 ·Status: UNKNOWN ·Phase: NA